Duck hepatitis virus: adaptation of a plaque assay to determine 50 per cent end points with duck sera.
An assay to determine 50 per cent neutralisation end points of duck anti-duck hepatitis virus sera was developed using a plaque assay to quantify residual virus. The optimal conditions were determined. Ducklings produce a serological response within four days of vaccination and the response reaches a maximum within nine days.
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology*; D002460:Cell Line; D004372:Ducks / Q000276:immunology*; D004770:Enterovirus / Q000276:immunology*; D004371:Hepatitis Virus, Duck / Q000254:growth & development / Q000276:immunology*; D007106:Immune Sera / Q000276:immunology; D009500:Neutralization Tests; D012672:Semliki forest virus / Q000254:growth & development / Q000276:immunology; D014611:Vaccination / Q000662:veterinary; D010948:Viral Plaque Assay; D014765:Viral Vaccines / Q000276:immunology
D000914:Antibodies, Viral; D007106:Immune Sera; D014765:Viral Vaccines